Kurosh RAHIMI

Kurosh Rahimi is an Associate Clinical Professor at the University of Montreal's Faculty of Medicine, Department of Pathology and Cell Biology. He specializes in gynecological pathology and gynecological cancer research, focusing on fundamental, therapeutic, and diagnostic advancements. His affiliations include the Centre hospitalier de l’Université de Montréal (CHUM) and the Quebec Trophoblastic Disease Registry. Dr. Rahimi has contributed to standardizing protocols for gynecologic oncology specimen management and has been involved in significant research initiatives like the Terry Fox Study Committee for Ovarian Cancer and the Canadian Ovarian Cancer Research Consortium (TFRI).

His research interests revolve around ovarian and endometrial cancers, with a focus on biomarker validation, histopathological analysis, and diagnostic algorithm development. Recent publications highlight studies on SATB2 expression in ovarian carcinomas, serous endometrial intraepithelial carcinoma features, and microcystic tumor invasion patterns. He collaborates extensively, contributing to international cohorts like the COEUR project.

Affiliations and roles include investigative research in cancer at the CHUM and leadership in diagnostic pathology for trophoblastic diseases. His work bridges clinical practice and research, aiming to improve diagnostic accuracy and therapeutic strategies in gynecologic malignancies.